Literature DB >> 2493783

Relationship of sulfated glycosaminoglycans and cholesterol content in normal and arteriosclerotic human aorta.

J Hollmann1, A Schmidt, D B von Bassewitz, E Buddecke.   

Abstract

Sulfated glycosaminoglycans were extracted from arteriosclerotic and adjacent nonarteriosclerotic areas of human aortas from persons ages 28 to 83 years; the glycosaminoglycans were compared with the cholesterol and triglyceride content of the tissues. Sulfated glycosaminoglycans were isolated after proteolytic digestion of defatted arterial tissue and were quantified after reductive labeling with NaB3H4. The amount of glycosaminoglycans in the aorta increased with the age of the person and the cholesterol content (degree of arteriosclerosis) of the aorta. The proportion of chondroitin sulfate/dermatan sulfate increased significantly with age and cholesterol content, whereas the corresponding amounts of heparan sulfate decreased.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493783     DOI: 10.1161/01.atv.9.2.154

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  19 in total

1.  Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.

Authors:  Karin Tran-Lundmark; Phan-Kiet Tran; Gabrielle Paulsson-Berne; Vincent Fridén; Raija Soininen; Karl Tryggvason; Thomas N Wight; Michael G Kinsella; Jan Borén; Ulf Hedin
Journal:  Circ Res       Date:  2008-07-03       Impact factor: 17.367

2.  Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.

Authors:  S Pillarisetti; L Paka; J C Obunike; L Berglund; I J Goldberg
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  Cholesterol-dependent changes of glycosaminoglycan pattern in human aorta.

Authors:  R Kruse; M Merten; K Yoshida; A Schmidt; W Völker; E Buddecke
Journal:  Basic Res Cardiol       Date:  1996 Sep-Oct       Impact factor: 17.165

4.  Advanced glycation endproduct changes to Bruch's membrane promotes lipoprotein retention by lipoprotein lipase.

Authors:  Marisol Cano; Natalia Fijalkowski; Naoshi Kondo; Sonny Dike; James Handa
Journal:  Am J Pathol       Date:  2011-06-12       Impact factor: 4.307

5.  Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr-/- mice.

Authors:  Tao Tang; Patricia G Wilson; Joel C Thompson; Christina Nelson; Meghan H Yoder; Lisa R Tannock
Journal:  J Lipid Res       Date:  2013-06-07       Impact factor: 5.922

6.  Increased atherosclerosis in mice with increased vascular biglycan content.

Authors:  Joel C Thompson; Tao Tang; Patricia G Wilson; Meghan H Yoder; Lisa R Tannock
Journal:  Atherosclerosis       Date:  2014-04-15       Impact factor: 5.162

7.  Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque.

Authors:  L Heickendorff; T Ledet; L M Rasmussen
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

Review 8.  Proteoglycan mediated lipoprotein retention: a mechanism of diabetic atherosclerosis.

Authors:  Lisa R Tannock; Victoria L King
Journal:  Rev Endocr Metab Disord       Date:  2008-06-27       Impact factor: 6.514

9.  Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus.

Authors:  F Wasty; M Z Alavi; S Moore
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

10.  Ultrastructural localization of endogenous albumin in human aortic tissue by protein A-gold immunocytochemistry.

Authors:  I Londoño; Y Leclerc; M Bendayan
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.